Background Foci of the HIV epidemic and helminthic infections largely overlap geographically. Treatment options for helminth infections are limited, and there is a paucity of drug-development research in this area. Limited evidence suggests that antiretroviral therapy (ART) reduces prevalence of helminth infections in HIV-infected individuals. We investigated whether ART exposure and cotrimoxazole preventive therapy (CTX-P) is associated with a reduced prevalence of helminth infections. Methodology and Principal Findings This cross-sectional study was conducted at a primary HIV-clinic in Lambaréné, Gabon. HIV-infected adults who were ART-na？ve or exposed to ART for at least 3 months submitted one blood sample and stool and urine samples on 3 consecutive days. Outcome was helminth infection with intestinal helminths, Schistosoma haematobium, Loa loa or Mansonella perstans. Multivariable logistic regression was used to assess associations between ART or CTX-P and helminth infection. In total, 408 patients were enrolled. Helminth infection was common (77/252 [30.5%]). Filarial infections were most prevalent (55/310 [17.7%]), followed by infection with intestinal helminths (35/296 [11.8%]) and S. haematobium (19/323 [5.9%]). Patients on CTX-P had a reduced risk of Loa loa microfilaremia (adjusted odds ratio (aOR) 0.47, 95% CI 0.23-0.97, P = 0.04), also in the subgroup of patients on ART (aOR 0.36, 95% CI 0.13-0.96, P = 0.04). There was no effect of ART exposure on helminth infection prevalence. Conclusions/Significance CTX-P use was associated with a decreased risk of Loa loa infection, suggesting an anthelminthic effect of antifolate drugs. No relation between ART use and helminth infections was established.
References
[1]
Fincham JE, Markus MB, Adams VJ. Could control of soil-transmitted helminthic infection influence the HIV/AIDS pandemic. Acta Trop 2003; 86(2–3): 315–33. pmid:12745135 doi: 10.1016/s0001-706x(03)00063-9
[2]
Hotez PJ, Kamath A. Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis 2009; 3(8): e412. doi: 10.1371/journal.pntd.0000412. pmid:19707588
[3]
Harms G, Feldmeier H. HIV infection and tropical parasitic diseases—deleterious interactions in both directions? Trop Med Int Health 2002; 7(6): 479–88. pmid:12031069 doi: 10.1046/j.1365-3156.2002.00893.x
[4]
Slutsker L, Marston BJ. HIV and malaria: interactions and implications. Curr Opin Infect Dis 2007; 20(1): 3–10. pmid:17197875 doi: 10.1097/qco.0b013e328012c5cd
[5]
Walson J, Singa B, Sangaré L, Naulikha J, Piper B, Richardson B, et al. Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi-site, randomised trial. Lancet Infect Dis. 2012;12:925–32. doi: 10.1016/S1473-3099(12)70207-4. pmid:22971323
[6]
Vercruysse J, Albonico M, Behnke JM, Kotze AC, Prichard RK, McCarthy JS, et al. Is anthelmintic resistance a concern for the control of human soil-transmitted helminths? Int J Parasitol Drugs Drug Resist. 2011; 1(1): 14–27. doi: 10.1016/j.ijpddr.2011.09.002. pmid:24533260
[7]
Wang W, Wang L, Liang YS. Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitol Res. 2012; 111(5):1871–1877. doi: 10.1007/s00436-012-3151-z. pmid:23052781
[8]
Fokom-Domgue J, Pion SD, Gounoue R, Akame J, Nguipdop-Djomo P, Twum-Danso NA, et al. Absence of an association between Plasmodium falciparum infection and post-ivermectin Loa-related non-neurologic serious adverse events. Am J Trop Med Hyg. 2014; 90(2): 335–338. doi: 10.4269/ajtmh.13-0189. pmid:24420781
[9]
Bachur TP, Vale JM, Coelho IC, Queiroz TR, Chaves CS. Enteric parasitic infections in HIV/AIDS patients before and after the highly active antiretroviral therapy. Braz J Infect Dis 2008; 12(2): 115–22. pmid:18641847 doi: 10.1590/s1413-86702008000200004
[10]
Adamu H, Wegayehu T, Petros B. High prevalence of diarrhoegenic intestinal parasite infections among non-ART HIV patients in Fitche Hospital, Ethiopia. PLoS One. 2013; 8(8):e72634. doi: 10.1371/journal.pone.0072634. pmid:23991132
[11]
Abate E, Belayneh M, Gelaw A, Idh J, Getachew A, Alemu S, et al. The impact of asymptomatic helminth co-infection in patients with newly diagnosed tuberculosis in north-west Ethiopia. PLoS One. 2012; 7(8): e42901. doi: 10.1371/journal.pone.0042901. pmid:22952620
[12]
Teklemariam Z, Abate D, Mitiku H, Dessie Y. Prevalence of intestinal parasitic infection among HIV positive persons who are naive and on antiretroviral treatment in Hiwot Fana Specialized University Hospital, Eastern Ethiopia. ISRN AIDS. 2013: 324329. doi: 10.1155/2013/324329. pmid:24052888
[13]
Taye B, Desta K, Ejigu S, Dori GU. The magnitude and risk factors of intestinal parasitic infection in relation to Human Immunodeficiency Virus infection and immune status, at ALERT Hospital, Addis Ababa, Ethiopia. Parasitol Int. 2014; 63(3): 550–6. doi: 10.1016/j.parint.2014.02.002. pmid:24603288
[14]
Ivan E, Crowther NJ, Rucogoza AT, Osuwat LO, Munyazesa E, Mutimura E, et al. Malaria and helminthic co-infection among HIV-positive pregnant women: prevalence and effects of antiretroviral therapy. Acta Trop. 2012; 124(3): 179–84. doi: 10.1016/j.actatropica.2012.08.004. pmid:22940013
[15]
Lacey E. Mode of action of benzimidazoles. Parasitol Today. 1990; 6(4): 112–5. pmid:15463312 doi: 10.1016/0169-4758(90)90227-u
van der Valk M, Casula M, Weverlingz GJ, van Kuijk K, van Eck-Smit B, Hulsebosch HJ, et al. Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy. Antivir Ther. 2004; 9(3): 385–393. pmid:15259901
[18]
C？té HC. Possible ways nucleoside analogues can affect mitochondrial DNA content and gene expression during HIV therapy. Antivir Ther. 2005;10 Suppl 2:M3–11. pmid:16152702
[19]
Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. . Accessed 22 December 2014.
[20]
Flateau C, Le Loup G, Pialoux G. Consequences of HIV infection on malaria and therapeutic implications: a systematic review. Lancet Infect Dis. 2011; 11(7): 541–56. doi: 10.1016/S1473-3099(11)70031-7. pmid:21700241
[21]
World health organization, WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. 2007. . Accessed 20-03-2015.
[22]
van den Biggelaar AH, Rodrigues LC, van RR, van der Zee JS, Hoeksma-Kruize YC, Souverijn JH, et al. Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren. J Infect Dis 2004; 189(5): 892–900. pmid:14976607 doi: 10.1086/381767
[23]
Adegnika AA, Ramharter M, Agnandji ST, Ateba NU, Issifou S, Yazdanbakhsh M, et al. Epidemiology of parasitic co-infections during pregnancy in Lambarene, Gabon. Trop Med Int Health 2010; 15(10): 1204–1209. doi: 10.1111/j.1365-3156.2010.02598.x. pmid:20636299
[24]
Akue JP, Nkoghe D, Padilla C, Moussavou G, Moukana H, Mbou RA, et al. Epidemiology of concomitant infection due to Loa loa and Mansonella perstans in Gabon. PLoS Negl Trop Dis 2011; 5(10): e1329. doi: 10.1371/journal.pntd.0001329. pmid:22022623
[25]
UNAIDS. Report on the Global AIDS Epidemic 2013. . Accessed 22 December 2014.
[26]
Tarafder MR, Carabin H, Joseph L, Balolong E Jr, Olveda R, McGarvey ST. Estimating the sensitivity and specificity of Kato-Katz stool examination technique for detection of hookworms, Ascaris lumbricoides and Trichuris trichiura infections in humans in the absence of a “gold standard.” Int. J. Parasitol. 2010; 40:399–404. doi: 10.1016/j.ijpara.2009.09.003. pmid:19772859
[27]
Koga K, Kasuya S, Khamboonruang C, Sukhavat K, Ieda M, Takatsuka N, et al. A modified agar plate method for detection of Strongyloides stercoralis. Am. J. Trop. Med. Hyg. 1991; 45:518–521. pmid:1951861
[28]
Goldsmid JM. Studies on the laboratory diagnosis of human filariasis: preliminary communication. J Clin Path. 1970; 23: 632–635. pmid:5529998 doi: 10.1136/jcp.23.7.632
[29]
Pion SD, Demanou M, Oudin B, Boussinesq M. Loiasis: the individual factors associated with the presence of microfilaraemia. Ann Trop Med Parasitol. 2005;99(5): 491–500. pmid:16004708 doi: 10.1179/136485905x51300
[30]
Rajan TV, Nelson FK, Shultz LD, Shultz KL, Beamer WG, Yates J, et al. Influence of gonadal steroids on susceptibility to Brugia malayi in scid mice. Acta Trop. 1994; 56(4): 307–14. pmid:8023754 doi: 10.1016/0001-706x(94)90102-3
[31]
Walson JL, Stewart BT, Sangaré L, Mbogo LW, Otieno PA, Piper BK, et al. Prevalence and correlates of helminth co-infection in Kenyan HIV-1 infected adults. PLoS Negl Trop Dis. 2010; 4(3): e644. doi: 10.1371/journal.pntd.0000644. pmid:20361031
[32]
Ivan E, Crowther NJ, Mutimura E, Osuwat LO, Janssen S, Grobusch MP. Helminthic infections rates and malaria in HIV-infected pregnant women on anti-retroviral therapy in Rwanda. PLoS Negl Trop Dis. 2013; 7(8): e2380. doi: 10.1371/journal.pntd.0002380. pmid:23967365
[33]
Janssen S, Rossatanga EG, Jurriaans S, ten Berge IJ, Grobusch MP. Triple infection with HIV-1, HTLV-1 and Strongyloides stercoralis, rendering CD4+ T-cell counts a misleading entity. Antivir Ther. 2013; 18(7): 949–51. doi: 10.3851/IMP2692. pmid:24152969
[34]
Elliott AM, Mawa PA, Joseph S, Namujju PB, Kizza M, Nakiyingi JS, et al. Associations between helminth infection and CD4+ T cell count, viral load and cytokine responses in HIV-1-infected Ugandan adults. Trans R Soc Trop Med Hyg. 2003; 97(1): 103–8. pmid:12886815 doi: 10.1016/s0035-9203(03)90040-x
[35]
Sangaré LR, Herrin BR, John-Stewart G, Walson JL. Species-specific treatment effects of helminth/HIV-1 co-infection: a systematic review and meta-analysis. Parasitology. 2011; 138(12): 1546–58. doi: 10.1017/S0031182011000357. pmid:21729353
[36]
Webb EL, Ekii AO, Pala P. Epidemiology and immunology of helminth-HIV interactions. Curr Opin HIV AIDS 2012; 7(3): 245–53. doi: 10.1097/COH.0b013e32835210cd. pmid:22411451
[37]
Sharma RD, Bag S, Tawari NR, Degani MS, Goswami K, Reddy MV. Exploration of 2, 4-diaminopyrimidine and 2, 4-diamino-s-triazine derivatives as potential antifilarial agents. Parasitology. 2013; 140(8): 959–65. doi: 10.1017/S0031182013000309. pmid:23552564
[38]
Schweitzer BI, Dicker AP, Bertino JR. Dihydrofolate reductase as a therapeutic target. FASEB J. 1990;4:2441–52. pmid:2185970
[39]
Reeves DS, Wilkinson PJ. The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues. Infection. 1979; 7 Suppl 4: S330–41. pmid:389810 doi: 10.1007/bf01639009
[40]
Noireau F, Apembet JD. Comparison of thick blood smear and saponin haemolysis for the detection of Loa loa and Mansonella perstans infections. J Trop Med Hyg. 1990; 93(6): 390–392. pmid:2270002
[41]
Nikolay B, Brooker SJ, Pullan RL. Sensitivity of diagnostic tests for human soil-transmitted helminth infections: a meta-analysis in the absence of a true gold standard. Int J Parasitol. 2014; 44(11): 765–774. doi: 10.1016/j.ijpara.2014.05.009. pmid:24992655
[42]
Inês Ede J, Souza JN, Santos RC, Souza ES, Santos FL, Silva ML, et al. Efficacy of parasitological methods for the diagnosis of Strongyloides stercoralis and hookworm in faecal specimens. Acta Trop. 2011; 120(3): 206–210. doi: 10.1016/j.actatropica.2011.08.010. pmid:21896267
[43]
Adegnika AA, Zinsou JF, Issifou S, Ateba-Ngoa U, Kassa RF, Feugap EN, et al. Randomized, controlled, assessor-blind clinical trial to assess the efficacy of single- versus repeated-dose albendazole to treat Ascaris lumbricoides, Trichuris trichiura, and hookworm infection. Antimicrob Agents Chemother. 2014; 58(5): 2535–2540. doi: 10.1128/AAC.01317-13. pmid:24550339
